News | Brachytherapy Systems | March 15, 2017

Xoft System Treats 3,000 Early-Stage Breast Cancer Patients With Intraoperative Radiation Therapy

Company showcases one-day breast cancer treatment technology at Physicians’ Education Resource 34th Annual Miami Breast Cancer Conference

iCAD, Xoft Axxent Electronic Brachytherapy System, eBx, 3,000 early-stage breast cancer patients, Miami Breast Cancer Conference

March 15, 2017 — iCAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with intraoperative radiation therapy (IORT) using the Xoft Axxent Electronic Brachytherapy (eBx) System. The Xoft System and its suite of products were showcased in the Xoft booth during Physicians’ Education Resource (PER)’s 34th Annual Miami Breast Cancer Conference at the Fontainebleau Miami Beach Hotel in Miami Beach, Fla., March 9-12, 2017.

IORT is a procedure that allows radiation oncologists and breast cancer surgeons to work together to deliver a full course of radiation treatment in one day to select women diagnosed with early-stage breast cancer. Traditional external beam radiation therapy (EBRT) involves daily radiation treatments for six to eight weeks, while IORT with the Xoft System can be completed in as little as eight minutes. IORT delivers a full course of targeted radiation from inside the body, directly within the tumor cavity, targeting cancer cells and reducing the risk of damage to nearby healthy tissue including tissue in the heart, lungs and ribs. A growing body of favorable clinical data supports the use of IORT in candidates meeting specific selection criteria.

“IORT with the Xoft System offers patients a number of unique benefits, including shorter treatment times, fewer side effects, reduced costs and added convenience compared to traditional treatment,” said Barbara Schwartzberg, M.D., FACS, breast surgeon, Sarah Cannon/HealthONE, Rose Medical Center, Denver. “By treating early-stage breast cancer in just one day, eligible patients are often able to return to their daily lives within days and better maintain their quality of life.”

The multidisciplinary Miami Breast Cancer Conference brings together surgical, medical and radiation oncology experts with the aim of fostering awareness of state-of-the-art treatments for breast cancer in each therapeutic area, encouraging cross-team cooperation in the clinic.

The Xoft System is U.S. Food and Drug Administration (FDA)-cleared for the treatment of cancer anywhere in the body, including early-stage breast cancer, non-melanoma skin cancer and gynecological cancers.

For more information: www.xoftinc.com

Related Content

high-intensity focused ultrasound, HIFU, prostate tissue ablation, after radiotherapy, EDAP TMS SA, Ablatherm, British Journal of Urology International study
News | Focused Ultrasound Therapy | March 29, 2017
EDAP TMS SA announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU (high-intensity...
iCAD, PowerLook Tomo Detection, computer-aided detection software, CAD, digital breast tomosynthesis, DBT, RSNA 2017
Technology | Computer-Aided Detection Software | March 27, 2017
March 27, 2017 — iCAD announced that PowerLook Tomo Detection received Premarket Approval (PMA) from the U.S.
VERT, virtual environment radiotherapy, radiation therapy, patient anxiety, Thomas Jefferson University study
News | Radiation Therapy | March 27, 2017
March 27, 2017 — Radiation therapists and physicians know that education can reduce anxiety before radiation treatmen
proton therapy, recurrent lung cancer, clinical study, IMPT, 2017 Multidisciplinary Thoracic Cancers Symposium
News | Proton Therapy | March 24, 2017
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for...
GE Healthcare, Senographe Pristina mammography system, launch, RSNA 2017, patient comfort
News | Mammography | March 24, 2017
GE Healthcare announced the launch of its new Senographe Pristina mammography system, designed to make breast screening...
lung cancer, radiation therapy, immune checkpoint inhibitors, 2017 Multidisciplinary Thoracic Cancers Symposium, clinical study
News | Lung Cancer | March 22, 2017
An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors (ICPIs)...
SBRT, stereotactic body radiation therapy, early-stage lung cancer, patients 80 and older, 2017 Multidisciplinary Thoracic Cancers Symposium, study
News | Stereotactic Body Radiation Therapy (SBRT) | March 20, 2017
Patients in their 80s and 90s who have early-stage lung cancer but cannot undergo an operation can be treated safely...
Solis Mammography, minimize recall rates, false positives, breast cancer, women's health
News | Mammography | March 16, 2017
Solis Mammography recently released a statement taking issue with incorrectly interpreted terminology used by reporters...
Parascript, AccuDetect CAD for Mammography, computer-aided detection, NCoBC 2017
News | Computer-Aided Detection Software | March 15, 2017
Parascript will exhibit at the National Consortium of Breast Centers (NCoBC) 27th Conference, March 11-17, 2017, in Las...
reducing radiation therapy, breast cancer, cut treatment costs, Duke Cancer Institute study
News | Radiation Therapy | March 14, 2017
March 14, 2017 — Over half of older women with early stage breast cancer received more...
Overlay Init